From Medscape Pulmonary Medicine

Coverage from the

European Respiratory Society (ERS) International Congress 2017

September 09 - 13, 2017; Milan, Italy

September 09 - 13, 2017 Milan, Italy

ERS Mepolizumab Showing Promise for High-Risk Eosinophilic COPD A biologic that targets interleukin-5 could reduce COPD exacerbations in patients with high blood eosinophil counts, new research shows.
Medscape Medical News, September 13, 2017
ERS Tezepelumab Promising in Adults With Poorly Controlled Asthma Tezepelumab significantly reduced exacerbation rates relative to placebo in adults with poorly controlled asthma despite combined use of bronchodilators and inhaled glucocorticoids, a study found.
Medscape Medical News, September 8, 2017

Conference News

ERS CPAP Safe for Obesity Hypoventilation Syndrome With Apnea
Medscape Medical News, September 14, 2017
ERS Mepolizumab Showing Promise for High-Risk Eosinophilic COPD
Medscape Medical News, September 13, 2017
ERS Exposure to Disinfectants Linked to COPD
Medscape Medical News, September 12, 2017

ERS Children With Asthma Prescribed Antibiotics Unnecessarily
Medscape Medical News, September 11, 2017
ERS Tezepelumab Promising in Adults With Poorly Controlled Asthma
Medscape Medical News, September 8, 2017
ERS First Results of Biologics for COPD Eagerly Awaited
Medscape Medical News, August 30, 2017

Popular News From ERS 2016

Vitamin D Eases Asthma, Cochrane Review Finds After vitamin D supplementation, asthma patients experience fewer severe exacerbations and medical emergencies, researchers report, but questions remain.
Medscape Medical News, Sep 8, 2016
Early Exposure to Antibiotics Augments Allergy, Eczema Risk There is an association between exposure to antibiotics in the first 2 years of life and the development of hayfever or eczema, new research shows.
Medscape Medical News, Sep 9, 2016
Major Trial: Forgo Whole-Brain RT in Lung Cancer Whole-brain radiotherapy is routinely used in lung cancer patients with multiple brain metastases, but a major trial shows no significant survival or QoL benefit.
Medscape Medical News, Sep 4, 2016

Medscape Pulmonary Medicine© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resources